However, improved hematoma resolution observed with Nrf2 activators could also be due to the attenuation of inflammatory and oxidative signaling and subsequent prevention of hematoma expansion or improvement in brain recovery mechanisms. The gene discussed is NFE2L2; the disease is hematoma.